Global blood therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Global blood therapeutics Contact Number

Contact Us Global Blood Therapeutics

7 hours ago Gbt.com Get All

833-428-2677

181 Oyster Point Boulevard. South San Francisco, CA 94080. USA. 1-833-GBT-CORP. (1-833-428-2677) View on Google Maps.

Website: https://www.gbt.com/about/contact-us/

Category: Contact SupportShow more

Global Blood Therapeutics, Inc. (gbt) contact finder tool

7 hours ago Easyleadz.com Get All

650-741-7700

14 rows · Name : Global Blood Therapeutics, Inc. (gbt) Industry : Healthcare: Headquarters : San Francisco, …

Contact Number : 650-741-7700
Industry : Healthcare
Headquarters : San Francisco, California, United States
Name : Global Blood Therapeutics, Inc. (gbt)

Website: https://www.easyleadz.com/company/global-blood-therapeutics-inc-gbt

Category: Contact SupportShow more

IR Contact Global Blood Therapeutics, Inc.

8 hours ago Ir.globalbloodtx.com Get All

833-428-2677

Global Blood Therapeutics. 181 Oyster Point Boulevard South San Francisco, CA 94080. 1-883-GBT-CORP (1-833-428-2677) Investor inquiries [email protected]

Website: http://ir.globalbloodtx.com/contact-ir

Category: Contact SupportShow more

Home Global Blood Therapeutics

Just Now Gbt.com Get All

Home - Global Blood Therapeutics. Hope is what feeds us, connects us and moves us forward. It’s what we bring to life through access to innovative treatment and determined advocacy. Learn more. Science is our bedrock, our backbone. It’s how we make good happen and find ways to …

Website: https://www.gbt.com/

Category: Home PhoneShow more

Global Blood Therapeutics Crunchbase Company Profile

5 hours ago Crunchbase.com Get All

650-741-7700

Contact Email [email protected] Phone Number 650-741-7700. GBT is a clinical-stage biopharmaceutical company that focuses on discovering, developing, and delivering innovative treatments that provide hope to underserved patient communities. GBT is developing its product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease.

Founded: 2012
Founder: Matthew Jacobson

Website: https://www.crunchbase.com/organization/global-blood-therapeutics

Category: Contact NumberShow more

Global Blood Therapeutics, Inc. Company Profile South

3 hours ago Dnb.com Get All

Find company research, competitor information, contact details & financial data for Global Blood Therapeutics, Inc. of South San Francisco, CA. Get the latest business insights from Dun & Bradstreet.

Accounts Receivable: $2.64
Inventories: $1.28
Cash and Cash Equivalents: $302.24
Other Current Assets: $321.85

Website: https://www.dnb.com/business-directory/company-profiles.global_blood_therapeutics_inc.979dba67f17eaa191613b5927bcc7df2.html

Category: Contact NumberShow more

GBT Overview, News & Competitors ZoomInfo.com

5 hours ago Zoominfo.com Get All

GBT Announces New Employment Inducement Grants SOUTH SAN FRANCISCO, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on August 1, 2021, the compensation committee of GBT’s board of directors granted 12 new employees restricted stock units for an aggregate of 33,050 shares of the company’s common stock.

Website: https://www.zoominfo.com/c/global-blood-therapeutics-inc/38963850

Category: Contact NumberShow more

Global Blood Therapeutics Email Format gbt.com Emails

8 hours ago Rocketreach.co Get All

Global Blood Therapeutics Email Format. Global Blood Therapeutics uses 8 email formats, with first last (ex. [email protected]) being used 25.8% of the time. Get Verified Emails for Global Blood Therapeutics Employees. Global Blood Therapeutics's Email Format.

Website: https://rocketreach.co/global-blood-therapeutics-email-format_b5f1c0f5f42d35e2

Category: Contact NumberShow more

Global Blood Therapeutics, Inc. in Charlotte, NC Company

3 hours ago Bizapedia.com Get All

Global Blood Therapeutics, Inc. is a North Carolina Foreign Business Corporation filed On November 25, 2019. The company's filing status is listed as Current-Active and its File Number is 1921061. The Registered Agent on file for this company is United Agent Group Inc. and is located at …

Location: CA

Website: https://www.bizapedia.com/nc/global-blood-therapeutics-inc.html

Category: Contact NumberShow more

Global Blood Therapeutics, Inc. (GBT) Company Profile

3 hours ago Finance.yahoo.com Get All

See the company profile for Global Blood Therapeutics, Inc. (GBT) including business summary, industry/sector information, number of employees, business summary, corporate governance, key

Website: https://finance.yahoo.com/quote/GBT/profile

Category: Contact NumberShow more

Global Blood Therapeutics

6 hours ago Gbt-portal.idea-point.com Get All

Contact You are currently leaving our site. External links are being provided as a convenience and for information purposes only; they do not constitute an endorsement or an approval by Global Blood Therapeutics .

Website: https://gbt-portal.idea-point.com/Default.aspx

Category: Contact NumberShow more

Hedge Funds Continue Dumping Global Blood Therapeutics Inc

5 hours ago Insidermonkey.com Get All

The number of bullish hedge fund bets were trimmed by 7 lately. Global Blood Therapeutics Inc (NASDAQ:GBT) was in 19 hedge funds’ portfolios at the end of March. The all time high for this

1. Author: Debasis Saha

Website: https://www.insidermonkey.com/blog/hedge-funds-continue-dumping-global-blood-therapeutics-inc-gbt-965930/

Category: Contact NumberShow more

Global Blood Therapeutics Inc Company Profile GlobalData

5 hours ago Globaldata.com Get All

Global Blood Therapeutics Inc Deals. View up-to-date information on Global Blood Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into key Global Blood Therapeutics

Website: https://globaldata.com/company-profile/global-blood-therapeutics-inc/deals/

Category: Contact NumberShow more

Global Blood Therapeutics Employees, Board Members

2 hours ago Crunchbase.com Get All

Number of Employee Profiles 15. Global Blood Therapeutics has 15 current employee profiles, including SVP, Operations Nazila Habibizad. Nazila Habibizad SVP, Operations. David L. Johnson Chief Commercial Officer. Jack Taunton Founder. Jeffrey Farrow Chief Financial Officer. Craig Muir Founder. Ted W. …

Website: https://www.crunchbase.com/organization/global-blood-therapeutics/people

Category: Contact NumberShow more

GBT (Global Blood Therapeutics) Company Profile Office

2 hours ago Craft.co Get All

GBT (Global Blood Therapeutics) has 352 employees across 2 locations and $123.8 M in annual revenue in FY 2020. See insights on GBT (Global Blood Therapeutics) including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Website: https://craft.co/global-blood-therapeutics

Category: Contact NumberShow more

Global Blood Therapeutics Online Medical Information

3 hours ago Gbtmedinfo.com Get All

Global Blood Therapeutics Online Medical Information . In order to respond to your inquiry, we need to collect your name and contact information. Your information will be processed to document and respond to your request, and in accordance with GBT’s privacy policy,

Website: https://gbtmedinfo.com/

Category: Contact NumberShow more

Global Blood Therapeutics Inc Company Profile and News

8 hours ago Bloomberg.com Get All

Company profile page for Global Blood Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information

Website: https://www.bloomberg.com/profile/company/GBT:US

Category: Contact NumberShow more

Global Blood Therapeutics Wiki Finpedia

4 hours ago Finpedia.co Get All

1. Global Blood Therapeutics (GBT) is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. The company's lead product candidate is voxelotor (previously known as GBT440), an oral, once-daily therapy that modulates hemoglobin’s affinity for oxygen, which the company believe inhibits hemoglobin polymerization in sickle cell disease, or SCD.1 Global Blood Therapeutics is currently evaluating voxelotor in SCD in a Phase 3 clinical trial in adult and adolescent patients with SCD. In addition, Global Blood Therapeutics is evaluating the safety and pharmacokinetics of single and multiple doses of voxelotor in a Phase 2a clinical trial of adolescent and pediatric patients with SCD, and in July 2017 the company announced that Global Blood Therapeutics has expanded this open-label trial to include a new single-dose cohort in children aged 6-11. In December 2015, the Food and Drug Adminis...

Website: https://finpedia.co/bin/Global Blood Therapeutics/

Category: Contact NumberShow more

Global Blood Therapeutics Number of Employees 20142021

1 hours ago Macrotrends.net Get All

Global Blood Therapeutics number of employees from 2014 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing and

Website: https://www.macrotrends.net/stocks/charts/GBT/global-blood-therapeutics/number-of-employees

Category: Contact NumberShow more

Global Blood Therapeutics Biocom California

6 hours ago Biocom.org Get All

Contact us here: [email protected] About Global Blood Therapeutics . Biotech Company Headquartered in San Francisco, California and founded in 2012, GBT is a clinical-stage bio pharmaceutical company that discovers, develops and commercializing therapeutics in order to treat blood-based disorders.

Website: https://www.biocom.org/member/global-blood-therapeutics/

Category: Contact NumberShow more

Susan Rader Page's email & phone number Head of Employee

1 hours ago Signalhire.com Get All

View Susan Rader Page's email address: [email protected] & phone: +1-xxx-xxx-4855's profile as Head of Employee Experience at Global Blood Therapeutics, located in St Paul, Minnesota. Find contacts: direct phone number, email address, work experience.

Website: https://www.signalhire.com/profiles/susan-rader-page's-email/11405467

Category: Phone NumberShow more

Annette Beiderbeck Head of Market Access Europe & GCC

2 hours ago Apollo.io Get All

View Annette Beiderbeck's business profile as Head of Market Access Europe & GCC at Global Blood Therapeutics. Find Annette's email address, mobile number, work history, and more.

Website: https://www.apollo.io/people/Annette/Beiderbeck/57df9192a6da980b5c77ff12

Category: Contact NumberShow more

Trade Alert: The Independent Director Of Global Blood

4 hours ago Nasdaq.com Get All

Global Blood Therapeutics insiders own about US$43m worth of shares. That equates to 2.5% of the company. This level of insider ownership is good but just short of being particularly stand-out.

Website: https://www.nasdaq.com/articles/trade-alert:-the-independent-director-of-global-blood-therapeutics-inc.-nasdaq:gbt-scott

Category: Contact NumberShow more

Scott Morrison's email & phone number Member of the

9 hours ago Signalhire.com Get All

View Scott Morrison's email address: [email protected] & phone: +1-xxx-xxx-4134's profile as Member of the Board of Directors at Global Blood Therapeutics, located in San Francisco Bay Area. Find contacts: direct phone number, email address, work experience.

Website: https://www.signalhire.com/profiles/scott-morrison's-email/15233897

Category: Phone NumberShow more

Global Blood Therapeutics (GBT) Company Profile & Overview

5 hours ago Stockanalysis.com Get All

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. The company offers Oxbryta tablets, an oral, once-daily therapy for sickle cell disease (SCD). It is evaluating the safety and pharmacokinetics of single and multiple doses of

Website: https://stockanalysis.com/stocks/gbt/company/

Category: Contact NumberShow more

Global Blood Therapeutics Stock: Attempting To Classify

4 hours ago Seekingalpha.com Get All

1. Author: Biologics
Published: Aug 07, 2021

Website: https://seekingalpha.com/article/4446328-global-blood-therapeutics-attempting-to-classify-the-investment

Category: Contact NumberShow more

GBT Stock Price Global Blood Therapeutics Inc. Stock

7 hours ago Marketwatch.com Get All

Global Blood Therapeutics downgraded to neutral from overweight at JPMorgan, price target cut to $36 from $70 Jun. 28, 2021 at 11:29 a.m. ET by Tonya Garcia Global Blood Therapeutics reiterated as

Website: https://www.marketwatch.com/investing/Stock/GBT

Category: Contact NumberShow more

Why Shares of Global Blood Therapeutics Are Soaring Today

3 hours ago Fool.com Get All

Monday's rise is a good example of a bounce back for blood therapy biotech Global Blood Therapeutics ( NASDAQ:GBT). The stock closed at $27.55 on Friday, hitting a low of $25.61 during the day's

Website: https://www.fool.com/investing/2021/08/23/why-shares-of-global-blood-therapeutics-is-soaring/

Category: Contact NumberShow more

Global Blood Therapeutics Healthcare Compliance Program

8 hours ago Ir.gbt.com Get All

As of July 1, 2021, to the best of its knowledge, and based on a good faith belief, Global Blood Therapeutics, Inc. is in compliance with its Compliance Program and the requirements of California Health & Safety Code §§ 119400-119402. As a result of the continuous evolution of the pharmaceutical industry regulatory environment,

Website: https://ir.gbt.com/static-files/406903cb-093e-48c9-bdc3-943cd7a400c2

Category: Contact NumberShow more

Home Global Therapeutics Corporation

5 hours ago Globaltherapeuticscorp.com Get All

Testing. Global Therapeutics is bringing to market one of the first rapid point-of-care tests for the COVID-19. This test detects both the first and late markers, IgM/IgG antibodies via finger-prick or blood samples. The test can be used for detection of carriers that are either symptomatic or asymptomatic.

Website: https://globaltherapeuticscorp.com/

Category: Home PhoneShow more

GLOBAL BLOOD THERAPEUTICS, INC. : Shareholders Board

6 hours ago Marketscreener.com Get All

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company is developing its initial product candidate, GBT440, as an oral, once-daily therapy for sickle cell disease (SCD).

Website: https://www.marketscreener.com/quote/stock/GLOBAL-BLOOD-THERAPEUTICS-23320379/company/

Category: Contact NumberShow more

GLOBAL BLOOD THERAPEUTICS, INC. POLITICAL ACTION …

5 hours ago Fec.gov Get All

We don't have GLOBAL BLOOD THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (GBT PAC) for 2021–2022. This can be because: We’re still processing the data. Try looking for raw versions of committee filings. Raw files are only available for electronic filers.

Website: https://www.fec.gov/data/committee/C00788661/

Category: Contact NumberShow more

Global Blood Therapeutics Inc. (NASDAQ:GBT) Could See A

3 hours ago Marketingsentinel.com Get All

Global Blood Therapeutics Inc. (NASDAQ:GBT)’s traded shares stood at 1.0 million during the last session, with the company’s beta value hitting 1.03. At the close of trading, the stock’s price was $25.97, to imply a decrease of -1.22% or -$0.32 in intraday trading. The GBT share’s 52-week hi

Website: https://marketingsentinel.com/2021/09/16/global-blood-therapeutics-inc-nasdaqgbt-could-see-a-148-32-or-even-more-loss-in-stock-price/

Category: Contact NumberShow more

GLOBAL BLOOD THERAPEUTICS UK LIMITED Overview (free

5 hours ago Find-and-update.company-information.service.gov.uk Get All

for GLOBAL BLOOD THERAPEUTICS UK LIMITED (12850868) People. for GLOBAL BLOOD THERAPEUTICS UK LIMITED (12850868) More. for GLOBAL BLOOD THERAPEUTICS UK LIMITED (12850868) Registered office address. C/O Legalinx Limited Tallis House, 2 Tallis Street, Temple, London, United Kingdom, EC4Y 0AB. Company status. Active.

Website: https://find-and-update.company-information.service.gov.uk/company/12850868

Category: Contact NumberShow more

Global Blood Therapeutics Inc. (GBT) is primed for

7 hours ago Investchronicle.com Get All

Global Blood Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $52.49 on 01/27/21, with the lowest value was $32.52 for the same time period, recorded on 06/28/21.

Website: https://investchronicle.com/2021/06/29/global-blood-therapeutics-inc-gbt-is-primed-for-evolution-with-the-beta-value-of-1-04-2/

Category: Contact NumberShow more

Working at Global Blood Therapeutics Glassdoor

4 hours ago Glassdoor.com Get All

Global Blood Therapeutics Overview. Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. Founded in 2011, GBT is delivering on …

Website: https://www.glassdoor.com/Overview/Working-at-Global-Blood-Therapeutics-EI_IE1077090.11,36.htm

Category: Contact NumberShow more

GLOBAL BLOOD THERAPEUTICS, INC. : Target Price Consensus

8 hours ago Marketscreener.com Get All

Mean consensus: BUY: Number of Analysts: 21: Last Close Price: 30,17 $ Average target price: 72,47 $ Spread / Average Target

Website: https://www.marketscreener.com/quote/stock/GLOBAL-BLOOD-THERAPEUTICS-23320379/consensus/

Category: Contact NumberShow more

Global Blood Therapeutics Inc. (NASDAQ:GBT) loss 1.22%

Just Now Baxterreport.com Get All

Global Blood Therapeutics Inc. (GBT) saw downtrend of -1.22% in the recent trading with $25.97 being its most recent. The current price level -59.73% lower than the highest price of $64.49 marked by the stock while trading over the past 52-weeks, whereas it is 1.92% higher than the lowest price of $25.48 the company dropped to over past 52-weeks.

Website: https://baxterreport.com/2021/09/16/global-blood-therapeutics-inc-nasdaqgbt-loss-1-22-is-it-right-time-to-buy/

Category: Contact NumberShow more

Global Blood Therapeutics, Inc. Forecasted to Earn FY2021

2 hours ago Marketbeat.com Get All

Global Blood Therapeutics (NASDAQ:GBT) last announced its quarterly earnings data on Monday, August 2nd. The company reported ($1.12) EPS for the quarter, beating the Zacks' consensus estimate of ($1.19) by $0.07. Global Blood Therapeutics had a negative return on equity of 68.58% and a negative net margin of 161.55%.

Website: https://www.marketbeat.com/instant-alerts/nasdaq-gbt-analyst-earnings-estimates-2021-08-2-3/

Category: Contact NumberShow more

Global Blood Therapeutics: Jobs LinkedIn

3 hours ago Linkedin.com Get All

Global Blood Therapeutics 11,358 followers on LinkedIn. Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing

Website: https://www.linkedin.com/company/global-blood-therapeutics/jobs

Category: Contact NumberShow more

Dawn Svoronos Member of the Board Global Blood

9 hours ago Ca.linkedin.com Get All

About. Results-oriented and innovative pharmaceutical executive with 30 years of commercial pharmaceutical industry experience across a number of geographic regions (Canada, United States, Asia Pacific, western and eastern Europe) Member of the Board of Directors of a number of publicly traded biopharmaceutical and medical device companies.

Title: Member of the Board at Global Blood
Location: Elizabethtown-Kitley, Ontario, Canada
1. 500+ connections

Website: https://ca.linkedin.com/in/dawn-svoronos-13118b31

Category: Contact NumberShow more

GBT Reports Second Quarter 2021 Financial Results Global

3 hours ago Ir.gbt.com Get All

833-428-4968

Patients are advised to call their doctor for medical advice about side effects. Side effects can be reported to FDA at 1-800-FDA-1088. Side effects can also be reported to Global Blood Therapeutics at 1-833-428-4968 (1-833-GBT-4YOU). Full Prescribing Information for Oxbryta is available at Oxbryta.com. About Global Blood Therapeutics

Website: https://ir.gbt.com/news-releases/news-release-details/gbt-reports-second-quarter-2021-financial-results

Category: Contact NumberShow more

Global Blood Therapeutics Interview Questions Glassdoor

4 hours ago Glassdoor.com Get All

I interviewed at Global Blood Therapeutics (South San Francisco, CA) in Aug 2018. Interview. The process was very organized, effective, and handled with professionalism. Phone interviews with HR and Hiring Manager, followed by an on-site interview. Detailed information (e.g., direction, parking, schedule) was provided in …

Website: https://www.glassdoor.com/Interview/Global-Blood-Therapeutics-Interview-Questions-E1077090.htm

Category: Contact NumberShow more

Global Blood Therapeutics (GBT): Increasing Specialization

9 hours ago Seekingalpha.com Get All

1. As usual, I'll deliver a brief corporate overview for new investors. If you are familiar with the firm, I suggest that you skip to the subsequent section. Operating out of San Francisco, California, GBT dedicatesits efforts to the development and launch of novel medicines to serve the unmet needs in the debilitating blood disorder coined sickle cell disease ("SCD"). Figure 2: Therapeutic pipeline (Source: GBT) Being a blood heme disorder (i.e., hemoglobinopathy), SCD causes deformation of red blood cells (“RBC”) that occurs in oxygen deficiency states. I noted in the prior article, Figure 3: Sickle cell disease statistic (Source: GBT)
2. Author: Biosci Capital Partners
Published: May 10, 2021

Website: https://seekingalpha.com/article/4426526-global-blood-therapeutics-increasing-specialization-in-scd

Category: Contact NumberShow more

Global Blood Therapeutics, Inc. (NASDAQ:GBT) Given Average

Just Now Marketbeat.com Get All

The company has a fifty day moving average price of $31.24. Global Blood Therapeutics has a 1 year low of $25.48 and a 1 year high of $64.49. The firm has a market cap of $1.77 billion, a PE ratio of -6.61 and a beta of 1.01. Global Blood Therapeutics (NASDAQ:GBT) last posted its …

Website: https://www.marketbeat.com/instant-alerts/nasdaq-gbt-consensus-analyst-rating-2021-08-2-3/

Category: Contact NumberShow more

What Is So Great About Global Blood Therapeutics Inc. (GBT

8 hours ago Marketingsentinel.com Get All

Investors are also buoyed by the number of investors in a company, with Global Blood Therapeutics Inc. having a total of 327 institutions that hold shares in the company. The top two institutional holders are Bank of America Corporation with over 6.2 million shares worth more than $252.78 million.

Website: https://marketingsentinel.com/2021/07/26/what-is-so-great-about-global-blood-therapeutics-inc-gbt/

Category: Contact NumberShow more

Rock star Growth Puts Global Blood Therapeutics (NASDAQ

6 hours ago News.yahoo.com Get All

And in the last year Global Blood Therapeutics had an earnings before interest and tax (EBIT) loss, truth be told. Indeed, in that time it burnt through US$216m of cash and made a loss of US$266m. But at least it has US$288.1m on the balance sheet to spend on growth, near-term. Importantly, Global Blood Therapeutics's revenue growth is hot to trot.

Website: https://news.yahoo.com/rock-star-growth-puts-global-080506279.html

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is global blood therapeutics?

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. The company offers Oxbryta tablets, an oral, once-daily therapy for sickle cell disease (SCD).

Why is science important to global blood therapeutics?

It’s what we bring to life through access to innovative treatment and determined advocacy. Science is our bedrock, our backbone. It’s how we make good happen and find ways to answer significant unmet needs. It’s our promise. Community is our strength and our inspiration.

What does global blood therapeutics do for sickle cell disease?

The company offers Oxbryta tablets, an oral, once-daily therapy for sickle cell disease (SCD). It is evaluating the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase 2a clinical trial of adolescent and pediatric patients with SCD.

Brand New Updated

Popular Brands

Godrej
Gbl
Geely
Gati
Gic
Gevo
Geron
Gaia
Gpa